Vertex Pharmaceuticals (VRTX)

Net Change in Cash

$649.20M

Quarterly · Period ending: · USD

VRTX logo

VRTX Net Change in Cash

Latest reported$649.20M
VRTX Quarterly Net Change in Cash ($26.00M → $649.20M)
High-resolution chart · PNG

VRTX net change in cash history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Net Change in Cash — Quarterly (USD)
Period endingNet Change in Cash (USD)
-54,135,000
-99,428,000
-149,339,000
288,221,000
-8,542,000
160,202,000
9,100,000
11,200,000
400,000
600,000
100,000
1,500,000
1,300,000
1,300,000
1,600,000
1,100,000
12,000,000
150,100,000
2,600,000
78,100,000
6,000,000
400,000
700,000
-4,600,000
600,000
400,000
14,900,000
-300,000
-200,000
57,500,000
-400,000
-500,000
2,900,000
-400,000
-300,000
-300,000
-300,000
-300,000
25,300,000
26,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.